Document is current
Any future updates will be listed below
-
Authors
Reback, Cathy J.
Landovitz, Raphael J.
Benkeser, David
Jalali, Ali
Shoptaw, Steven
Li, Michael J.
Mata, Raymond P.
Ryan, Danielle
Jeng, Philip J.
Murphy, Sean M. https://orcid.org/0000-0001-9104-0670
-
Funding
Funding for this research was provided by:
National Institute on Drug Abuse (R01DA056888, P30DA040500, K01DA051329)
National Institute of Mental Health (P30MH58107)
- License Information
-
More Information
Article History
Received: 1 September 2023
Accepted: 25 June 2024
First Online: 9 November 2024
Declarations
:
: This trial and its procedures have been approved by the Western Institutional Review Board (#20224309), which serves as the IRB of record for all participating institutions and subject recruitment venues. The study was registered as a clinical trial (Clinical Trials #NCT05934877)
: Not applicable.
: Dr. Murphy served on an advisory board panel for Indivior, outside of the submitted work. The remaining authors declare that they have no competing interests.
